SecBot SecBot
SC 13D/A ·Filed Nov 20, 2026
DA

DAVI

DAVION HEALTHCARE PLC
NEUTRAL
Impact 3/10
Horizonimmediate Processed1d 22h ago SEC0001683168-26-008975
Activist stake amendment (position change)
Actionable Insight • Neutral

The gift reduces insider concentration but Kaye still holds 34.68%, maintaining control. No change in stated purpose or demands. Monitor for any subsequent 13D amendments that could signal a shift in strategy or further distribution of shares.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Executive Chairman Jack Kaye gifted 1,600,000 ordinary shares of Davion Healthcare to four individuals on November 19, 2026, reducing his beneficial ownership from 10,268,948 to 8,668,948 shares (34.68% of outstanding). The gifts were made without consideration and Kaye retains no voting or dispositive power over the transferred shares. This is a de-escalation of his concentrated insider position but does not change his role as Executive Chairman or his stated intentions.

Key Financial Metrics

Stake
34.68%
Investor
Jack Kaye

Key Facts

  • Jack Kaye gifted 1,600,000 ordinary shares on November 19, 2026 via four separate bona fide gifts (500K, 500K, 300K, 300K shares)
  • Beneficial ownership reduced from 10,268,948 to 8,668,948 shares (34.68% of 25M outstanding)
  • No consideration received; no voting or dispositive power retained over gifted shares
  • Kaye remains Executive Chairman and a director of Davion Healthcare
  • Prior stake was 10,268,948 shares (approximately 41.1% based on 25M outstanding); this filing reduces it by ~6.4 percentage points

Financial Impact

1,600,000 ordinary shares transferred via gift; no cash consideration. At the $26M market cap and 25M shares outstanding, the gifted shares represent ~6.4% of the company, worth approximately $1.66M at the snapshot price.

insider ownership percentage

Risk Factors

  • Gifts could precede further insider selling or distribution, though no sale has occurred
  • Reduced insider alignment may lower perceived commitment to shareholders
  • No change in control or governance structure; Kaye remains Executive Chairman

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13D/A Filing (Primary)0001683168-26-008975
Document: 0001683168-26-008975-index.html0001683168-26-008975
Document: 0001683168-26-008975.txt0001683168-26-008975

US Market Status

Market Closed · Opens Mon (26h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 20, 2026